01/10/2026
Do you or someone you love suffer from moderate or severe dry mouth after radiation therapy? π«¦
MeiraGTx is currently enrolling patients with moderate or severe dry mouth resulting from radiation therapy for head and neck cancer. The trial is called the AQUAx2 study.
has partnered with to help spread the word on this important ongoing study that will determine if the investigational gene therapy, AAV2-hAQP1 (the study drug), has an effect on dry mouth symptoms and the amount of saliva produced, and to see if it is safe and well-tolerated.
Scan the QR Code to see if you qualify!